Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q16937390> ?p ?o }
Showing triples 1 to 13 of
13
with 100 triples per page.
- Q16937390 subject Q7145142.
- Q16937390 abstract "DepoDur CII, previously known as DepoMorphine, is a morphine sulfate extended-release liposome injection (see Depot injection), product of Pacira Pharmaceuticals (formerly SkyePharma PLC). It was approved by the U.S. Food and Drug Administration (FDA) in 2004 for use as a post-surgical pain reliever. In Europe, it was approved by the Medicines and Healthcare Products Regulatory Agency in 2006.It is a one-time injection (during or shortly after surgery) that maintains a therapeutically effective level of morphine in the patient's bloodstream for 48 hours.".
- Q16937390 wikiPageExternalLink www.depodur.com.
- Q16937390 wikiPageExternalLink www.pacira.com.
- Q16937390 wikiPageWikiLink Q1916302.
- Q16937390 wikiPageWikiLink Q204711.
- Q16937390 wikiPageWikiLink Q245359.
- Q16937390 wikiPageWikiLink Q410454.
- Q16937390 wikiPageWikiLink Q7145142.
- Q16937390 wikiPageWikiLink Q81225.
- Q16937390 comment "DepoDur CII, previously known as DepoMorphine, is a morphine sulfate extended-release liposome injection (see Depot injection), product of Pacira Pharmaceuticals (formerly SkyePharma PLC). It was approved by the U.S. Food and Drug Administration (FDA) in 2004 for use as a post-surgical pain reliever.".
- Q16937390 label "DepoDur".
- Q16937390 homepage www.depodur.com.